Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment

Status unconfirmed · Not applicable

Conditions studied: Primary Hypothyroidism.

In brief

Our hypothesis is that hypothyroid patients on DTE may have a decrease in symptoms, an improvement of cognitive function, and an increase in sense of well-being/ quality of life equivalently compared with L-T4.

Key facts

Study ID

NCT01739972

Run by

Walter Reed National Military Medical Center

People needed

180

Starts

2012-05-01

Expected to finish

2014-05-01

Last updated by the study team

2012-12-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients will be between the ages of 18 to 65 and will have been on levothyroxine for primary hypothyroidism for at least 6 months.

You may not qualify if…

• Patients will be excluded if they have the following problems: pregnancy, plan for pregnancy in the next 12 months, cardiac disease, especially coronary artery disease, chronic obstructive lung disease, malabsorption disorder, gastrointestinal surgeries, significant renal or liver dysfunction, seizure disorders, thyroid and non-thyroid active cancers, uncontrolled psychosis, psychotropic medication use, steroid use, amiodarone, chemotherapy for cancer, iron supplement more than 325mg per day, carafate/ proton pump inhibitor use, cholestyramine use, and those with recent PCS orders who are expected to move out of the geographic area, age less than 18 years old or older than 65 years old.
• Patients scheduled for deployment will be excluded.

Where it is running

• Walter Reed National Military Medical Center — Bethesda, Maryland, United States (enrolling)
• Walter Reed National Military Medical Center, Endocrinology — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.